The Motley Fool
•Exscientia's stock soars on mild quarterly earnings beat
71% Informative
Exscientia, which harnesses AI in the discovery and development of pharmaceuticals, pub quarterly s first-quarter results well before market open.
The U.K.-based company earned $7.1 million in revenue for the period.
That was down notably Exscientia $8.6 EXAI l 6.04% t more than 6% e same quarter of 2022, Wednesday ceeded the average analyst projection of $6.3 million. 0.7% eed_ the day htText__Nx Exscientia pan> AI ummaryFeed_highLightText__NxlGi">U.K. first-quarter ext__NxlGi">EXS21546 $7.1 million 1/2 first< $8.6 million n class="summa the same quarter of 2022 lGi">earlier this month nearly $6.3 million ext__NxlGi">ExscientiaExscientia class="summaryFeed_highLightText__NxlGi"> $46.6 million pan> the quarter s="sum 0.38 Feed_highLightText__NxlGi">t year-ago > $19.1 million ed_highLightText__NxlGi">sixth Andrew Ho 0.40 s
VR Score
82
Informative language
92
Neutral language
55
Article tone
informal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links